Atrium Therapeutics awards new hire options for 13,500 shares, RSUs for 6,750 shares under inducement plan

• Atrium Therapeutics awarded inducement equity grants on Sept. 20, 2026 to one newly hired non-executive under its 2026 Employment Inducement Incentive Award Plan.
• Grant included non-qualified stock options for 13,500 shares with an exercise price of USD 8.95.
• Options vest 25% after one year, then monthly over 36 months, subject to continued service.
• Grant also included 6,750 restricted stock units, vesting 25% after one year, then annually over three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atrium Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA53090) on September 21, 2026, and is solely responsible for the information contained therein.